Signant Health and Lothar Medical to Commercialize Respiratory Assessment System for Trials

Signant Health and Lothar Medical have entered into a letter of intent to commercialize Lothar Medical's ALDS PRO respiratory assessment system for use in clinical trials.

The collaboration aims to combine Signant Health's electronic Clinical Outcome Assessment (eCOA) and digital endpoint capabilities with Lothar Medical's three-in-one ALDS PRO system.

The ALDS PRO system is designed to accurately measure respiratory function, providing three key respiratory metrics in a single device. This partnership intends to integrate these measurements into Signant Health's broader data capture and management solutions for clinical research.

Further details regarding specific commercial terms and timelines are expected to be announced at a later date. Signant Health provides technology solutions for clinical trials, while Lothar Medical focuses on respiratory diagnostics.